Search

everythinglearnresearchcommunity

for

Search:↓

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Finasteride may cause male infertility, stopping it can help.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

High doses of finasteride cause cell growth and tumors in mice.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Iron deficiency is not a significant cause of hair loss in women.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.